MétaCan
Menu
← Back to cohort

S3154 Long-Term Metabolic Outcomes of Endoscopic Sleeve Gastroplasty in Patients With Type 2 Diabetes: A Systematic Review

2025· article· en· W7114793357 on OpenAlexaboutno aff

Bibliographic record

VenueThe American Journal of Gastroenterology · 2025
Typearticle
Languageen
FieldMedicine
TopicBariatric Surgery and Outcomes
Canadian institutionsnot available
Fundersnot available
KeywordsDiabetes mellitusGlycemicWeight lossType 2 diabetesType 2 Diabetes MellitusMetabolic syndromeRetrospective cohort study

Abstract

fetched live from OpenAlex

Introduction: Endoscopic sleeve gastroplasty (ESG) is a minimally invasive procedure that reduces gastric volume by approximately 70% using endoscopic suturing. It has shown short-term metabolic benefits in patients with obesity and type 2 diabetes mellitus (T2DM), including improved glycemia, weight, blood pressure, liver enzymes, and lipid profiles. However, most data are limited to 6-24 months, and the long-term durability of these effects in T2DM remains unclear. The objective of this study is to determine the sustained impact of ESG on metabolic outcomes thereby contributing to a more complete understanding of ESG’s long-term role in the management of T2DM. Methods: We conducted a systematic review following PRISMA guidelines, searching PubMed, Embase, and Scopus from inception through March 2025. Inclusion criteria were prospective or retrospective studies reporting ≥3-year outcomes after ESG in adults with T2DM. We excluded studies involving non-adult populations, non-ESG bariatric therapies, follow-up <36 months, absence of extractable T2DM metabolic data, case series <10 patients, reviews or duplicates, and non-English papers without accessible full text. Primary outcomes included changes in glycemic control, diabetes remission rates, and total body weight loss (TBWL). Risk of bias was assessed using the Newcastle-Ottawa Scale. Results: Out of 161 records identified, 118 unique studies were screened after de-duplication. Three studies met inclusion criteria, with follow-up durations of 4 to 5 years and T2DM subgroups ranging from 14% to 44% of each cohort. Diabetes remission or improvement ranged from 51.2% to 66.7%. Only 1 study reported granular metabolic data, including a 0.42% absolute HbA1c reduction and improvement in insulin resistance. TBWL at 5 years ranged from 11.8% to 12.2% in 2 studies; a third reported 18.2% TBWL at 4 years. Risk of bias was low in 1 study and moderate in the other 2. Conclusion: Our study demonstrates that ESG is associated with sustained improvements in glycemic control, insulin resistance, and weight loss in patients with T2DM. Despite the limited number of long-term studies, available evidence indicates that the metabolic benefits of ESG can be maintained over time.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.007
metaresearch head score (Gemma)0.031
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (broad)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.991
Threshold uncertainty score0.037

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0070.031
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0090.008
Bibliometrics0.0100.013
Science and technology studies0.0010.001
Scholarly communication0.0030.002
Open science0.0020.001
Research integrity0.0020.001
Insufficient payload (model declined to judge)0.0080.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.006
GPT teacher head0.249
Teacher spread0.243 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicBariatric Surgery and Outcomes→French-language works237,207→